Arformoterol Tartrate Inhalation Solution
Product Images NDC 70436-151
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate Inhalation (NDC 70436-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 02)
This is a table that includes data for a clinical trial of a drug called arformoterol tartrate inhalation solution. The drug is being tested to see if it improves FEV (forced expiratory volume) in patients. The table shows the hours post-dose along the top and the number of participants in the trial on the left-hand side. The baseline FEV for each group is also provided in liters (L). It appears that the group receiving the 15 mcg dose of arformoterol tartrate inhalation solution twice a day had a slightly lower baseline FEV than the placebo group.*
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 04)
Carton Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 06)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5)
Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.